Thus, although accumulation of mutant p53 occurs only in cancer cells, in which most missense mutants are shown to be more stable than wild-type p53, the aggregation of different mutants seems to correlate with individual structural characteristics, which may affect their differential recognition and degradation route. Here, TP53 is linked to cancer.